Veralto Acquires Cleanwater1 in $465M Water Deal

Veralto has agreed to acquire Cleanwater1, a maker of on-site hypochlorite disinfection, solids management and odor filtration systems, for $465 million in cash, the company announced August 19, 2026. After estimated tax benefits, the net purchase price is approximately $452 million, a figure the release values at roughly 17 times Cleanwater1’s last-twelve-months adjusted EBITDA as of June 30, 2026. The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions.

The deal adds a chemical disinfection line to a Water Quality segment built around physical treatment. Cleanwater1 brings an installed base of approximately 25,000 units across municipal drinking water, wastewater and industrial applications, and generated approximately $135 million in sales over the twelve months ended June 30, 2026, of which about 25% were aftermarket sales — the parts, service and consumables revenue that flows off equipment already bolted down at treatment plants. Veralto described the technologies as complementary to its existing portfolio and said the acquisition expands it into adjacent, higher-growth water treatment applications.

Cleanwater1’s systems do the unglamorous end of treatment: generating chlorine disinfectant on site from salt, water and electricity rather than trucking in hazardous bulk chemicals, blending and feeding polymers and lime, and scrubbing odor from wastewater headworks. Its brand stable (Polyblend, Dynablend, Veloblend, PAX Mixers, Monoclor RCS, Microclor on-site hypochlorite generation and I-Box odor control) sells into the daily compliance operations of municipal utilities, the customer base where purchase orders follow permit requirements rather than capital cycles. Its stated end markets include municipal water quality, municipal wastewater, mining, oil, gas and chemical, food and beverage, and data centers.

“Cleanwater1’s differentiated water treatment technologies, deep application expertise and large installed base will further bolster our Water Quality segment,” said Jennifer L. Honeycutt, Veralto’s President and Chief Executive Officer, in the announcement. “This acquisition will expand our presence in attractive, faster-growing water treatment applications while creating meaningful opportunities to drive recurring revenue growth and deeper customer engagement.”

What Veralto Is Paying, and for What

The 17-times multiple is stated on the $452 million net price and, per the release’s own footnote, excludes any revenue or cost synergies expected after completion as well as one-time costs to achieve them. Against that, Veralto laid out the growth record it is buying: Cleanwater1’s sales have grown at a low double-digit compound annual rate since 2023, and the company expects that pace to continue over the next few years, citing Trojan Technologies’ customer relationships, aftermarket service into the installed base and the application of its Veralto Enterprise System commercial tools.

On earnings impact, the release commits to two defined benchmarks: the acquisition is expected to be neutral to modestly accretive to adjusted earnings per share in 2027, and to generate a return on invested capital at or above Veralto’s weighted average cost of capital by year four. Return on invested capital is defined in the release as the gross purchase price divided by the acquired business’s net operating profit after taxes.

The purchase lands on a balance sheet carrying fresh debt capacity. On May 27, 2026, Veralto priced $725 million of 4.850% senior notes due 2032 at 99.996% of principal, with estimated net proceeds of approximately $720.6 million earmarked for general corporate purposes, including refinancing, working capital and capital expenditures. Second-quarter free cash flow was $328 million on sales of $1,474 million.

A Second Water Deal in a Month

The Cleanwater1 agreement is Veralto’s second water treatment acquisition announcement in four weeks. On July 21, 2026, the company acquired Alfaa UV, a Mumbai-based ultraviolet treatment provider with more than 20 years in industrial and commercial applications, folded into Trojan Technologies to expand its presence in India and the Asia-Pacific region. Where Alfaa extends Trojan’s geographic reach, Cleanwater1 extends its chemistry: ultraviolet systems disinfect by light exposure, while hypochlorite generation gives utilities a residual disinfectant that persists through distribution networks, a pairing Veralto explicitly flagged, citing “clearly identified commercial synergies” between Cleanwater1 and Trojan’s UV business.

The deal cadence follows the pattern laid out in Veralto’s second-quarter 2026 results on July 28, 2026, where the company reported sales up 7.6% year-over-year to $1,474 million, with Water Quality sales up 10.1% and segment core sales growth of 5.7%, and cited bolt-on acquisitions including In-Situ, GlobalVision and Alfaa UV. Acquisitions contributed 2.4 percentage points of total company sales growth in the quarter, 3.2 points within Water Quality. Veralto raised full-year adjusted earnings guidance to $4.35 to $4.43 per share, representing 12% to 14% growth.

The Business Changing Hands

Cleanwater1 is itself an assembled platform. Baird Capital invested in the company, then known as UGSI Solutions, in June 2022; it rebranded as Cleanwater1 the following year and went on to complete four add-on acquisitions under Baird’s ownership, folding in polymer activation and conveyance systems, lime and odor-control equipment, water-industry automation and controls, and gas-phase filtration media. The company’s chief executive is David Stanton, who said joining Veralto opens opportunities to continue Cleanwater1’s growth trajectory. Baird Capital’s portfolio page describes an established, specified provider in the municipal water and wastewater market with high repeat-customer revenue — the thesis this sale now realizes.

The acquired financials come with the release’s stated constraints. Cleanwater1’s figures are unaudited, derived from information its management provided during due diligence with Veralto management adjustments, and have not been conformed to the accounting principles and policies Veralto follows; the release adds that definitions of sales, gross margin and operating profit may not align with Veralto’s own. The headline multiple likewise sits on an adjusted, non-GAAP EBITDA measure as Veralto defines it.

Assuming closing in the fourth quarter of 2026 as the release anticipates, the first stated financial checkpoint is 2027, when Veralto expects the deal to be neutral to modestly accretive to adjusted earnings per share; the return-on-capital benchmark follows by year four. Neither figure carries a dollar commitment beyond the purchase price itself — the commitments Veralto has made are the multiple paid, the aftermarket base acquired and the two benchmarks now on the record.